Advanced SearchSearch Tips
Development and Characterization of a Specific Anti-Caveolin-1 Antibody for Caveolin-1 Functional Study in Human, Goat and Mouse
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Development and Characterization of a Specific Anti-Caveolin-1 Antibody for Caveolin-1 Functional Study in Human, Goat and Mouse
Ke, Meng-Wei; Jiang, Yan-Nian; Li, Yi-Hung; Tseng, Ting-Yu; Kung, Ming-Shung; Huang, Chiun-Sheng; Cheng, Winston Teng-Kuei; Hsu, Jih-Tay; Ju, Yu-Ten;
  PDF(new window)
Caveolin-1 of the caveolin family of proteins regulates mammary gland development and has been shown to play a contradictory role in breast tumor progression. A specific anti-Caveolin-1 antibody will be useful for functional study of Caveolin-1 in different tissues. In this study, we generated a rabbit polyclonal antibody that specifically recognizes the N-terminal amino acids 50-65 of Caveolin-1. This polyclonal antibody specifically reacted with Caveolin-1 extracted from cells of different species, including human epithelial A431 cells, goat primary mammary epithelial cells and mice fibroblast NIH 3T3 cells, by Western blotting. Endogenous Caveolin-1 protein expressing in cells and normal human tissues was detected by this polyclonal antibody using immunocytofluorescent and immunohistochemical staining, respectively. Furthermore, an apparent decrease in Caveolin-1 expression in tumorous breast and colon tissues was detected by this polyclonal antibody. In conclusion, we have identified amino acids 50-65 of Caveolin-1, which contains an epitope that is specific to Caveolin-1 and is conserved in the human, goat and mouse. In future, this anti-Caveolin-1 antibody can be used to examine the progression of breast and colon cancers and to study functions of Caveolin-1 in human, goat and mouse cells.
Caveolin-1;Peptide Antibody;Breast Cancer;Goat;Cancer Marker;
 Cited by
Barnes, D. M., W. H. Harris, P. Smith, R. R. Millis and R. D. Rubens. 1996. Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients. Br. J. Cancer 74:1445-1451. crossref(new window)

Bush, W. S., G. Ihrke, J. M. Robinson and A. K. Kenworthy. 2006. Antibody-specific detection of caveolin-1 in subapical compartments of MDCK cells. Histochem. Cell Biol. 126:27-34. crossref(new window)

Capozza, F., T. M. Williams, W. Schubert, S. McClain, B. Bouzahzah, F. Sotgia and M. P. Lisanti. 2003. Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation. Am. J. Pathol. 162:2029-2039. crossref(new window)

Chen, S. T., S. Y. Lin, K. T. Yeh, S. J. Kuo, W. L. Chan, Y. P. Chu and J. G. Chang. 2004. Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers. Int. J. Mol. Med. 14:577-582.

Couet, J. M., M. Sargiacomo and M. P. Lisanti. 1997. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins: caveolin-binding negatively regulates tyrosine and serine/threonine kinase activities. J. Biol. Chem. 272:30429-30438. crossref(new window)

Cui, J., L. R. Rohr, G. Swanson, V. O. Speights, T. Maxwell and A. R. Brothman. 2001. Hypermethylation of the caveolin-1 gene promoter in prostate cancer. Prostate 46:249-256. crossref(new window)

Engelman, J. A., C. C. Wykoff, S. Yasuhara, K. S. Song, T. Okamoto and M. P. Lisanti. 1997. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J. Biol. Chem. 272:16374-16381. crossref(new window)

Engelman, J. A., R. J. Lee, A. Karnezis, D. J. Bearss, M. Webster, P. Siegel, W. J. Muller, J. J. Windle, R. G. Pestell and M. P. Lisanti. 1998. Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. J. Biol. Chem. 273:20448-20455. crossref(new window)

Engelman, J. A., X. L. Zhang and M. P. Lisanti. 1999. Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1). FEBS Lett. 448:221-230. crossref(new window)

Ho, C. C., P. H. Huang, H. Y. Huang, Y. H. Chen, P. C. Yang and S. M. Hsu. 2002. Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. Am. J. Pathol. 161:1647-1656. crossref(new window)

Jenkins, R., S. Takahashi, K. Delacey, E. Bergstralh and M. Lieber. 1998. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer. Genes Chromosomes Cancer 21:131-143. crossref(new window)

Joo, H. J., D. K. Oh, Y. S. Kim, K. B. Lee and S. J. Kim. 2004. Increased expression of caveolin-1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma. BJU Int. 93:291-296. crossref(new window)

Ju, H., R. Zou, V. J. Venema and R. C. Venema. 1997. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J. Biol. Chem. 272:18522-18525. crossref(new window)

Kato, K., Y. Hida, M. Miyamoto, H. Hashida, T. Shinohara, T. Itoh, S. Okushiba, S. Kondo and H. Katoh. 2002. Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer 94:929-933. crossref(new window)

Kerr, J., J. A. Leary, T. Hurst, Y. C. Shih, T. M. Antalis, M. Friedlander, E. Crawford, S. K. Khoo, B. Ward and G. Chenevix-Trench. 1996. Allelic loss on chromosome 7q in ovarian adenocarcinomas: two critical regions and a rearrangement of the PLANH1 locus. Oncogene 13:1815-1818.

Koleske, A. J., D. Baltimore and M. P. Lisanti. 1995. Reduction of caveolin and caveolae in oncogenically transformed cells. Proc. Natl. Acad. Sci. USA. 92:1381-1385.

Krajewska, W. M. and I. Maslowska. 2004. Caveolins: structure and function in signal transduction. Cell. Mol. Biol. Lett. 9:195-220.

Lavie, Y., G. Fiucci and M. Liscovitch. 1998. Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells. J. Biol. Chem. 273:32380-32383. crossref(new window)

Lee, H., D. S. Park, B. Razani, R. G. Russell, R. G. Pestell and M. P. Lisanti. 2002. Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer. Am. J. Pathol. 161:1357-1369. crossref(new window)

Li, J. T., A. H. Wang, P. Chen, H. B. Li, C. S. Zhang and L. X. Du. 2006. Relationship between the polymorphisms of 5' regulation region of prolactin gene and milk traits in Chinese Holstein dairy cows. Asian-Aust. J. Anim. Sci. 19:459-462.

Li, S., J. Couet and M. P. Lisanti. 1996. Src tyrosine kinases, G subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. J. Biol. Chem. 271:29182-29190. crossref(new window)

Lin, S. Y., K. T. Yeh, W. T. Chen, H. C. Chen, S. T. Chen and J. G. Chang. 2004. Promoter CpG methylation of caveolin-1 in sporadic colorectal cancer. Anticancer Res. 24:1645-1650.

Nestl, A., O. D. Von Stein, K. Zatloukal, W. G. Thies, P. Herrlich, M. Hofmann and J. P. Sleeman. 2001. Gene expression patterns associated with the metastatic phenotype in rodent and human tumors. Cancer Res. 61:1569-1577.

Okamoto, T., A. Schlegel, P. E. Scherer and M. P. Lisanti. 1998. Caveolins, a family of scaffolding proteins for organizing "reassembled signaling complexes" at the plasma membrane. J. Biol. Chem. 273:5419-5422. crossref(new window)

Pantschenko, A. G., J. Woodcock-Mitchell, S. L. Bushmich and T. J. Yang. 2000. Establishment and characterization of a caprine mammary epithelial cell line (CMEC). In vitro Cell Dev. Biol. Anim. 36:26-37. crossref(new window)

Park, D. S., H. Lee, C. Riedel, J. Hulit, P. E. Scherer, R. G. Pestell and M. P. Lisanti. 2001. Prolactin negatively regulates caveolin-1 gene expression in the mammary gland during lactation, via a Ras-dependent mechanism. J. Biol. Chem. 276:48389-48397.

Park, D. S., H. Lee, P. G. Frank, B. Razani, A. V. Nguyen, A. F. Parlow, R. G. Russell, J. Hulit, R. G. Pestell and M. P. Lisanti. 2002. Caveolin-1-deficient mice show accelerated mammary gland development during pregnancy, premature lactation, and hyperactivation of the Jak-2/STAT5a signaling cascade. Mol. Biol. Cell 13:3416-3430. crossref(new window)

Razani, B. and M. P. Lisanti. 2001. Caveolin-deficient mice: insights into caveolar function and human disease. J. Clin. Invest. 108:1553-1561.

Rothberg, K. G., J. E. Heuser, W. C. Donzell, Y. S. Ying, J. R. Glenney and R. G. Anderson. 1992. Caveolin, a protein component of caveolae membrane coats. Cell 68:673-682. crossref(new window)

Sager, R., S. Sheng, A. Anisowicz, G. Sotiropoulou, Z. Zou, G. Stenman, K. Swisshelm, Z. Chen, M. J. Hendrix, P. Pemberton, K. Rafidi and K. Ryan. 1994. RNA genetics of breast cancer: maspin as a paradigm. Cold Spring Harb. Symp. Quant. Biol. 59:537-546.

Sargiacomo, M., P. E. Scherer, Z. Tang, E. Kubler, K. S. Song, M. C. Sanders and M. P. Lisanti. 1995. Oligomeric structure of caveolin: implications for caveolae membrane organization. Proc. Natl. Acad. Sci. USA. 92:9407-9411

Seol, M. B., J. J. Bong and M. Baik. 2006. Involvement of Cathepsin D in apoptosis of mammary epithelial cells. Asian-Aust. J. Anim. Sci. 19:1100-1105

Shridhar, V., Q. C. Sun, O. J. Miller, G. P. Kalemkerian, J. Petros and D. I. Smith. 1997. Loss of heterozygosity on the long arm of human chromosome 7 in sporadic renal cell carcinomas. Oncogene 15:2727-2733. crossref(new window)

Sloan, E. K., K. L. Stanley and R. L. Anderson. 2004. Caveolin-1 inhibits breast cancer growth and metastasis. Oncogene 23:7893-7897. crossref(new window)

Smart, E. J., G. A. Graf, M. A. McNiven, W. C. Sessa, J. A. Engelman, P. E. Scherer, T. Okamoto and M. P. Lisanti. 1999. Caveolins, liquid-ordered domains, and signal transduction. Mol. Cell. Biol. 19:7289-7304.

Song, K. S., S. Li, T. Okamoto, L. A. Quilliam, M. Sargiacomo and M. P. Lisanti. 1996a. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. J. Biol. Chem. 271:9690-9697. crossref(new window)

Song, K. S., P. E. Scherer, Z. Tang, T. Okamoto, S. Li, M. Chafel, C. Chu, D. S. Kohtz and M. P. Lisanti. 1996b. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. J. Biol. Chem. 271:15160-15165. crossref(new window)

Sunaga, N., K. Miyajima, M. Suzuki, M. Sato, M. A. White, R. D. Ramirez, J. W. Shay, A. F. Gazdar and J. D. Minna. 2004. Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer. Cancer Res. 64:4277-4285. crossref(new window)

Wary, K. K., A. Mariotti, C. Zurzolo and F. G. Giancotti. 1998. A requirement of caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell 94:625-634. crossref(new window)

Wiechen, K., L. Diatchenko, A. Agoulnik, K. M. Scharff, H. Schober, K. Arlt, B. Zhumabayeva, P. D. Siebert, M. Dietel, R. Schafer and C. Sers. 2001. Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am. J. Pathol. 159:1635-1643. crossref(new window)

Wikman, H., J. Seppanen, V. K. Sarhadi, E. Kettunen, K. Salmenkivi, E. Kuosma, K. Vainio-Siukola, B. Nagy, A. Karjalainen, T. Sioris, J. Salo, J. Hollmen, S. Knuutila and S. Anttila. 2004. Caveolins as tumor markers in lung cancer detected by combined use of cDNA and tissue microarrays. J. Pathol. 203:584-593. crossref(new window)

Yang, G., L. D. Truong, T. L. Timme, C. Ren, T. M. Wheeler, S. H. Park, Y. Nasu, C. H. Bangma, M. W. Kattan, P. T. Scardino and T. C. Thompson. 1998. Elevated expression of caveolin is associated with prostate and breast cancer. Clin. Cancer Res. 4:1873-1880.

Zenklusen, J. C., I. Bieche, R. Lidereau and C. J. Conti. 1994a. $(C-A)_{n}$ microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer. Proc. Natl. Acad. Sci. USA. 91:12155-12158.

Zenklusen, J. C., J. C. Thompson, P. Troncoso, J. Kagan and C. J. Conti. 1994b. Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1. Cancer Res. 54:6370-6373.

Zenklusen, J. C., J. C. Thompson, A. J. Klein-Szanto and C. J. Conti. 1995. Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene. Cancer Res. 55:1347-1350.

Zhang, W., B. Razani, Y. Altschuler, B. Bouzahzah, K. E. Mostov, R. G. Pestell and M. P. Lisanti. 1998. Caveolin-1 inhibits epidermal growth factor-stimulated lamellipod extension and cell migration in metastatic mammary adenocarcinoma cells (MTLn3). J. Biol. Chem. 275:20717-20725. crossref(new window)